Researchers have uncovered insights into the role genetics may play in the varying effectiveness of weight-loss injections among individuals. Specifically, variations in two genes that influence gut hormone pathways, which control appetite and digestion, could help explain the differing outcomes and side effects associated with glucagon-like peptide 1 (GLP1) medications.<\/p>\n
The study, released in the journal Nature on Wednesday, may pave the way for integrating genetic data into obesity treatment strategies in the future.<\/p>\n
GLP1 receptor agonists, such as semaglutide (branded as Wegovy) and tirzepatide (sold under the name Mounjaro), are designed to replicate the action of natural gut hormones. These medications assist in regulating appetite, insulin secretion, and digestion, benefiting millions of individuals around the globe in their battle against obesity. Nonetheless, the reasons behind the disparities in weight loss and the occurrence of side effects among users have remained largely unclear.<\/p>\n
A research team from 23andMe, a non-profit medical research organization, analyzed data from 27,885 individuals using GLP1 drugs. Their investigation revealed that the GLP1 receptor variant known as rs10305420 was linked to slightly increased weight loss in those who possessed this variant compared to those who did not. Conversely, another variant, rs1800437, was tied to symptoms of nausea and vomiting in individuals taking tirzepatide, but it did not correlate with the amount of weight lost.<\/p>\n
The results indicate that genetic factors may influence individual responses to weight-loss injections. However, the researchers noted that the overall impact of genetics appears to be limited.<\/p>\n
Marie Spreckley, an expert in obesity from the University of Cambridge who was not involved in the research, remarked that the study offers credible evidence suggesting that genetic variations could influence treatment outcomes. \u201cNevertheless, the clinical significance of these genetic effects is minor,\u201d she stated. \u201cCrucially, non-genetic factors such as gender, type of medication, dosage, and treatment duration seem to account for a considerably larger share of the variability observed. According to the authors\u2019 model, most of the explained variance is attributed to these factors, with genetics contributing only a slight additional factor.\u201d<\/p>\n
Spreckley further emphasized that the findings align with broader research, suggesting that while there is significant variability in responses to GLP1 therapies, genetics is merely one aspect of a much more intricate scenario. Behavioral, clinical, and treatment-related elements remain the predominant influences on outcomes.<\/p>\n
In summary, this research represents a meaningful advancement in understanding the variability in responses to GLP1 medications and the potential for future personalized treatment approaches. However, the effects identified are modest, and the current evidence does not yet support the routine use of genetic information for guiding treatment decisions in clinical practice.<\/p>\n","protected":false},"excerpt":{"rendered":"
Researchers have uncovered insights into the role genetics may play in the varying effectiveness of weight-loss injections among individuals. Specifically, variations in two genes that influence gut hormone pathways, which control appetite and digestion, could help explain the differing outcomes and side effects associated with glucagon-like peptide 1 (GLP1) medications. The study, released in the […]<\/p>\n","protected":false},"author":2,"featured_media":5645,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[695,1399,1398,175,99,88,694],"tags":[],"class_list":["post-5646","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uk-health","category-uk-medical-research","category-uk-obesity","category-uk-science","category-uk-society","category-uk","category-uk-weight-loss-drugs"],"yoast_head":"\n